Bacterial and fungal infections after kidney transplantation

Current Opinion in Urology

Volumn 9, Issue 1, 1999, Pages 45-49

  Schmidt, Alice ^a   Oberbauer, Rainer ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; CEFAMANDOLE; CEFAZOLIN; COTRIMOXAZOLE; CYCLOSPORIN A; ERYTHROMYCIN; FLUCONAZOLE; GLYCOPEPTIDE; INTERLEUKIN 2 RECEPTOR ANTIBODY; PREDNISONE; PYRROLE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE; RIFAMPICIN; SULTAMICILLIN; TACROLIMUS;

ALLOGRAFT; BACTERIAL INFECTION; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MYCOSIS; NEPHROTOXICITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK FACTOR;

BACTERIAL INFECTIONS; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; MYCOSES; OPPORTUNISTIC INFECTIONS; RISK FACTORS;

EID: 0033001078     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-199901000-00008     Document Type: Review

References (38)

1. United States Renal Data System. USRDS 1998 Annual Data Report. Bethasda, MD: National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Disease; 1998. Since its creation in 1988 the United States Renal Data System has collected and analysed information on the incidence, prevalence, treatment, morbidity and mortality, of end-stage renal disease. These data have been published in an annual data report since then, and are available on the Internet (http://www.med.umich.edu/usrds/) and on CD-ROM.
2. Murphy JF, McDonald FD, Dawson M, Reite A, Turcotte J, Fekety FR Jr. Factors affecting the frequency of infection in renal transplant recipients. Arch Intern Med 1976; 136:670-677.
3. Brayman KL, Stephanian E, Matas AJ, Schmidt W, Payne WD, Sutherland DE, et al. Analysis of infectious complications occurring after solid-organ transplantation. Arch Surg 1992; 127:38-47.
4. Sia IG., Paya C.V., Infectious complications following renal transplantation. Surg Clin North Am 1998; 78:95-112.
5. West M, Sutherland DE, Matas AJ. Kidney transplant recipients who die with functioning grafts: serum creatinine level and cause of death. Transplantation 1996; 15:1029-1030.
6. Martinez-Marcos F, Cisneros J, Gentil M, Algarra G, Pereira P, Aznar J, Pachon J. Prospective study of renal transplant infections in 50 consecutive patients. Eur J Clin Microbiol Infect Dis 1994; 13:1023-1028.
7. Goya N, Tanabe K, Iguchi Y, Oshima T, Yagisawa T, Toma H, et al. Prevalence of urinary tract infection during outpatient follow-up after renal transplantation. Infection 1997; 25:101-105.
8. Tolkoft-Rubin NE, Rubin RH. Urinary tract infection in the immunocompromised host. Lessons from kidney transplantation and the AIDS epidemic. Infect Dis Clin North Am 1997; 11:707-717. Both kidney transplant patients and acquired immune deficiency syndrome patients have an increased incidence and severity of urinary tract infections. This review describes the causes, time course and treatment strategies for urinary tract infections in the immunocompromised host.
9. Rubin RH, Wolfson JS, Cosimi AB, Tolkoff-Rubin NE. Infection in the renal transplant recipient. Am J Med 1981; 70:405-411.
10. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998; 338:1741-1751. This review article focuses on the principles that guide infectious disease practice in transplantation, emphasizing the prevention and early recognition of infection. In particular, the time course of infections, cytomegalovirus and Epstein-Barr virus infections, as well as infections of the central nervous system, are discussed in detail.
11. Hornef MW, Bein G, Fricke L, Steinhoff J, Wagner HJ, Hinderer W, et al. Coincidence of Epstein-Barr virus reactivation, cytomegalovirus infection, and rejection episodes in renal transplant recipients. Transplantation 1995; 60:474-480.
12. Hibberd PL, Rubin RH. Renal transplantation and related infections. Semin Respir Infect 1993; 8:215-224.
13. John GT, Date A, Mathew CM, Jeyaseelan L, Jacob CK, Shastry JC A time table for infections after renal transplantation in the tropics. Transplantation 1996; 61:970-972.
14. Tolkoff-Rubin NE, Rubin RH. Opportunistic fungal and bacterial infection in the renal transplant recipient. J Am Soc Nephrol 1992; 2 (suppl 3):S264-S269.
15. Sakhuja V, Jha V, Varma PP, Joshi K, Chugh KS. The high incidence of tuberculosis among renal transplant recipients in India. Transplantation 1996; 61:211-215.
16. Nampoory MR, Khan ZU, Johny KV, Constandi JN, Gupta RK, Al-Muzairi I, et al. Invasive fungal infections in renal transplant recipients. J Infect 1996; 33:95-101.
17. Stephan RN, Munschauer CE, Kumar MS. Surgical wound infection in renal transplantation: outcome data in 102 consecutive patients without perioperative systemic coverage. Arch Surg 1997; 132:1315-1318. The incidence of wound infections could be reduced from 7 to 2% by improved organ procurement techniques and continuity in perioperative care.
18. Saxon A, Stevens RH, Ramer SJ, Clements PJ, Yu DT. Glucocorticoids administered in vivo inhibit human suppressor T lymphocyte function and diminished B lymphocyte responsiveness in vitro immunglobulin synthesis. J Clin Invest 1978; 61:922-930.
19. Corensek MJ, Stewart RW, Keys TF, Mehta AC, McHenry MC, Goormastic M. A multivariate analysis of risk factors for pneumonia following cardiac transplantation. Transplantation 1988; 46:860-865.
20. Palestine AG, Nussenblatt RB, Chan CC. Side effects of systemic cyctosporin in patients not undergoing transplantation. Am J Med 1984; 77:652-656.
21. Helderman JH, Van-Buren DH, Amend WJ Jr, Pirsch JD. Chronic immunosuppression of the renal transplant recipient. J Am Soc Nephrol 1994; 4 (suppl 1):S2-S9.
22. Gomez E, de Ona M, Aguado S, Tejada F, Nunez M, Portal C, et al. Cytomegalovirus preemptive therapy with gancyclovir in renal transplant patients treated with OKT3. Nephron 1996; 74:367-372.
23. Nashan B, Moore R, Amlot P, Schmidt AG, Abeywickrama K, Soulillou JP. Randomized trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group. Lancet 1997; 350:1193-1198. The incidence of infections after the administration of an interteukin-2 receptor blocker was not higher than that in placebo-treated patients.
24. Kane TD, Johnson SR, Alexander JW, Craycraft TK. Bacterial translocation in organ donors: clinical observations and potential risk factors. Clin Transplant 1997; 11:271-274. The incidence of bacterial translocation to mesenteric lymph nodes was nearly 50% and was associated with an increased morbidity in the recipients of organs from these donors.
25. Nelson PW, Delmonico FL, Tolkoff-Rubin NE, Cosimi AB, Fang LS. Russell PS, Rubin RH. Unsuspected donor pseudomonas infection causing arterial disruption after renal transplantation. Transplantation 1984; 37:313-314.
26. Drobniewski FA, Ferguson J. Tuberculosis in renal transplant units. Nephrol Dial Transplant 1996; 11:768-770.
27. Maranes A, Portoles J, Blanco J, Torrente J, Herrero J, Coronel F. et al. Aspergillus infection of a renal allograft without evidence of site of origin. Nephrol Dial Transplant 1996; 11:1639-1642.
28. Peddi VR, Hariharan S, First MR. Disseminated histoplasmosis in renal allograft recipients. Clin Transplant 1996; 10:160-165.
29. Ghasemian SM, Guleria AS, Khawand NY, Light JA. Diagnosis and management of the urologic complications of renal transplantation. Clin Transplant 1996; 10:218-223.
30. Oberbauer R, Banyai S, Schmidt A, Kornek G, Scheithauer W, Mayer G. Serum tumor markers after renal transplantation. Transplantation 1996; 62:1506-1509.
31. Lufft V, Kliem V, Behrend M, Pichlmayr R, Koch KM, Brunkhorst R. Incidence of Pneumocystis carinii pneumonia after renal transplantation. Impact of immunosuppression. Transplantation 1996; 62:421-423.
32. Higgins RM, Bloom SL, Hopkin JM, Morris PJ. The risks and benefits of low-dose cotrimozazol prophylaxis for Pneumocystis pneumonia in renal transplantation. Transplantation 1989; 47:558-560.
33. Fox BC, Sollinger HW, Belzer FO, Maki DG. A prospective, randomized, double-blind Study of trimethoprim-sulfamethoxazole for the prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis, Am J Med 1990; 89:255-274.
34. Moyses-Neto M, Costa RS, Reis MA, Ferraz AS, Saber LT, Batista ME, et al. Use of ciprofloxacin as a prophylactic agent in urinary tract infections in renal transplant recipients. Clin Transplant 1997; 11:446-452. An antibiotic prophylaxis with ciprofloxacin over 6 months after transplantation reduced the occurrence of urinary tract infection from 49 to 15% of patients.
35. Rubin HR, Tolkoff-Rubin NE. Antimicrobial strategies in the care of organ transplant recipients. Antimicrob Agents Chemother 1993; 37:619-624.
36. Pacholczyk MJ, Lagiewska B, Meszaros J, Szostek M, Rowinski W. Bacterial infections transmitted from the donor: antibiotic prophylaxis in the donor. Transplant Proc 1996; 28:184-185.
37. Rubin RH. Preemptive therapy in immunocompromised host. N Engl J Med 1991; 324:1057-1058.
38. Rubin R.H., Tolkoff-Rubin N.E. The impact of infections on the outcome of transplantation. Transplant Proc 1991; 23:2068-2074.